EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti‐VEGFR2 neutralising antibody slows the progression of multistep oral carcinogenesis

Yoichiro Shirogane, Yu Usami iD, Masashi Okumura, Katsutoshi Hirose iD, Kohei Naniwa, Kazunori Ikebe, Satoru Toyosawa

The Journal of Pathology · 2024

DOI: 10.1002/path.6357 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pathology, 2024. Verfasst von Yoichiro Shirogane und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Pathology, Osaka University Graduate School of Dentistry, Osaka, Japan. Hauptthemen laut MEDLINE: Mouth Neoplasms, Neovascularization, Pathologic, Vascular Endothelial Growth Factor Receptor-2, Disease Progression. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, The Nippon Foundation for Osaka University Project for Infectious Disease Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Angiogenesis plays an important role in cancer growth and metastasis, and it is considered a therapeutic target to control tumour growth following anti‐angiogenic therapy. However, it is still unclear when tissues initiate angiogenesis during malignant transformation from premalignant condition and whether this premalignant condition could be a therapeutic target of anti‐angiogenic therapy. In this study, we aimed to analyse the onset of angiogenesis by evaluating morphological and functional alterations of microvessels during oral multistep carcinogenesis using a 4‐nitroquinoline 1‐oxide (4NQO)‐induced oral carcinogenesis mouse model. In the study, we initially confirmed that with the use of 4NQO, oral lesions develop in a stepwise manner from normal mucosa through oral epithelial dysplasia (OED) to oral squamous cell carcinoma (OSCC). Evaluation of CD31‐immunostained specimens revealed that microvessel density (MVD) increases in a stepwise manner from OEDs. Histological and functional analyses revealed the structural abnormalities and leakage of blood vessels had already taken place in OED. Then we evaluated the expression profiles of Hif1a and Vegfa along with hypoxic status and found that OED exhibited increased Vegfa expression under hypoxic conditions. Finally, we tested the possibility of OEDs as a target of anti‐angiogenic therapy and found that anti‐VEGFR2 neutralising antibody in OED slowed the disease progression from OED to OSCC. These data indicate that an angiogenic switch occurs at the premalignant stage and morphological, and functional alterations of microvessels already exist in OED. These findings also elucidate the tumour microenvironment, which gradually develops along with carcinogenic processes, and highlight usefulness of the 4NQO‐induced carcinogenesis model in the study of epithelial and stromal components, which will support epithelial carcinogenesis. © 2024 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mouth NeoplasmsNeovascularization, PathologicVascular Endothelial Growth Factor Receptor-2Disease Progression4-Nitroquinoline-1-oxideAnimalsMiceAntibodies, NeutralizingCarcinogenesisDisease Models, AnimalPrecancerous ConditionsMaleAngiogenesis InhibitorsTumor MicroenvironmentSquamous Cell Carcinoma of Head and NeckHypoxia-Inducible Factor 1, alpha SubunitVascular Endothelial Growth Factor A

Stichwörter der Autor:innen

angiogenesisoral canceroral epithelial dysplasiapremalignanttumour microenvironment

Substanzen

Vascular Endothelial Growth Factor Receptor-24-Nitroquinoline-1-oxideKdr protein, mouseAntibodies, NeutralizingAngiogenesis InhibitorsHypoxia-Inducible Factor 1, alpha SubunitVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Pathology, Osaka University Graduate School of Dentistry, Osaka, Japan.
  • Department of Removable Prosthodontics and Gerodontology, Osaka University Graduate School of Dentistry, Osaka, Japan.
  • Department of Dentistry and Oral Surgery, Unit of Sensory and Locomotor Medicine, Division of Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
  • Center for Infectious Disease Education and Research (CiDER), Osaka University, Osaka, Japan.
  • Osaka University Graduate School of Dentistry, Osaka, Japan.
  • Department of Oral Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.

ORCID-Profile: Yu Usami, Katsutoshi Hirose

Förderung

  • Japan Society for the Promotion of Science
  • The Nippon Foundation for Osaka University Project for Infectious Disease Prevention

Zitieren

APA

Shirogane, Y., Usami, Y., Okumura, M., Hirose, K., Naniwa, K., Ikebe, K., & Toyosawa, S. (2024). Anti‐VEGFR2 neutralising antibody slows the progression of multistep oral carcinogenesis. The Journal of Pathology. https://doi.org/10.1002/path.6357

Vancouver

Shirogane Y, Usami Y, Okumura M, Hirose K, Naniwa K, Ikebe K, et al. Anti‐VEGFR2 neutralising antibody slows the progression of multistep oral carcinogenesis. The Journal of Pathology. 2024. doi:10.1002/path.6357

BibTeX
@article{Shirogane2024,
  author = {Shirogane, Yoichiro and Usami, Yu and Okumura, Masashi and Hirose, Katsutoshi and Naniwa, Kohei and Ikebe, Kazunori and Toyosawa, Satoru},
  title = {Anti‐VEGFR2 neutralising antibody slows the progression of multistep oral carcinogenesis},
  journal = {The Journal of Pathology},
  year = {2024},
  doi = {10.1002/path.6357}
}
Kostenlos starten →